Table 4.

Cytogenetic results of Imatinib treated CML patients presenting with cytopenia (n = 60)

Cytogenetic response (CR)	Percentage of metaphases positive	Number of patients
Complete CR	0% +ve	33
Major CR	1–35% +ve	13
Minor CR	36–65% +ve	10
Minimal CR	66–95% +ve	2
None	96–100% +ve	0
No dividing cells	–	2